Ambs, Stefan
National Institutes of Health · National Cancer Institute · Center for Cancer Research
15 papers on CoChatORCID 0000-0001-7651-9309
Most cited papers
- Verified
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences
MicroRNA in disease regulationCancer-related molecular mechanisms research
Cited by 5,697
- Verified
The chemical biology of nitric oxide: Implications in cellular signaling
Thomas, D. D., Ridnour, L. A., Isenberg, J. S., Flores-Santana, W., Switzer, C. H., Donzelli, S., Hussain, P., Vecoli, C., Paolocci, N., Ambs, S., et al. (2008) · Free Radical Biology and Medicine
Nitric Oxide and Endothelin EffectsRedox biology and oxidative stress
Cited by 975
- Verified
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., Wallace, T. A., Issaq, H. J., Zhou, M., Killian, J. K., et al. (2014) · Journal of Clinical Investigation
Cancer, Hypoxia, and MetabolismEpigenetics and DNA Methylation
Cited by 428
- Verified
Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients
Glynn, S. A., Boersma, B. J., Dorsey, T. H., Yi, M., Yfantis, H. G., Ridnour, L. A., Martin, D. N., Switzer, C. H., Hudson, R. S., Wink, D. A., et al. (2010) · Journal of Clinical Investigation
Breast Cancer Treatment StudiesEstrogen and related hormone effects
Cited by 254
- Verified
Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression
Ambs, S., Hussain, S. P., & Harris, C. C. (1997) · The FASEB Journal
Cancer-related Molecular PathwaysNitric Oxide and Endothelin Effects
Cited by 233
- Verified
Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression
Heinecke, J. L., Ridnour, L. A., Cheng, R. Y. S., Switzer, C. H., Lizardo, M. M., Khanna, C., Glynn, S. A., Hussain, S. P., Young, H. A., Ambs, S., et al. (2014) · Proceedings of the National Academy of Sciences
Nitric Oxide and Endothelin EffectsImmune cells in cancer
Cited by 177
- Verified
Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer
Ambs, S., Bennett, W. P., Merriam, W. G., Ogunfusika, M. O., Oser, S. M., Harrington, A. M., Shields, P. G., Felley-Bosco, E., Hussain, S. P., & Harris, C. C. (1999) · JNCI Journal of the National Cancer Institute
Nitric Oxide and Endothelin EffectsCancer-related Molecular Pathways
Cited by 166
- Verified
Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival
Tang, W., Zhou, M., Dorsey, T. H., Prieto, D. A., Wang, X. W., Ruppin, E., Veenstra, T. D., & Ambs, S. (2018) · Genome Medicine
Breast Cancer Treatment StudiesAdvanced Proteomics Techniques and Applications
Cited by 162
- Verified
S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer
Switzer, C. H., Glynn, S. A., Cheng, R. Y.-S., Ridnour, L. A., Green, J. E., Ambs, S., & Wink, D. A. (2012) · Molecular Cancer Research
HER2/EGFR in Cancer ResearchNitric Oxide and Endothelin Effects
Cited by 141
- Verified
Superoxide fluxes limit nitric oxide-induced signaling
Thomas, D. D., Ridnour, L. A., Espey, M. G., Donzelli, S., Ambs, S., Hussain, S. P., Harris, C. C., DeGraff, W., Roberts, D. D., Mitchell, J. B., et al. (2006) · Journal of Biological Chemistry
Nitric Oxide and Endothelin EffectsRedox biology and oxidative stress
Cited by 121
- Verified
Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer
Switzer, C. H., Cheng, R. Y.-S., Ridnour, L. A., Glynn, S. A., Ambs, S., & Wink, D. A. (2012) · Breast Cancer Research
Breast Cancer Treatment StudiesEstrogen and related hormone effects
Cited by 91
- Verified
Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer
Switzer, C. H., Glynn, S. A., Ridnour, L. A., Cheng, R. Y.-S., Vitek, M. P., Ambs, S., & Wink, D. A. (2011) · Trends in Pharmacological Sciences
Breast Cancer Treatment StudiesNitric Oxide and Endothelin Effects
Cited by 74
- Verified
Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation
Ridnour, L. A., Barasch, K. M., Windhausen, A. N., Dorsey, T. H., Lizardo, M. M., Yfantis, H. G., Lee, D. H., Switzer, C. H., Cheng, R. Y. S., Heinecke, J. L., et al. (2012) · PLoS ONE
Protease and Inhibitor MechanismsPI3K/AKT/mTOR signaling in cancer
Cited by 71
- Verified
A joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer
Auslander, N., Yizhak, K., Weinstock, A., Budhu, A., Tang, W., Wang, X. W., Ambs, S., & Ruppin, E. (2016) · Scientific Reports
Cancer, Hypoxia, and MetabolismMetabolomics and Mass Spectrometry Studies
Cited by 50
- Verified
ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
Mishra, P., Tang, W., & Ambs, S. (2018) · Molecular & Cellular Oncology
Cancer, Hypoxia, and MetabolismCancer, Lipids, and Metabolism
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free